These discrepancies could reflect either the expected fluctuations due to the small numbers of a rare disease, the possible higher efficacy of our panel in detecting variants in a very challenging gene (NF1 is very large and with known similar pseudogenes), or lastly, the possibility that more difficult GIST molecular diagnoses were prevalently directed to our specialized center. The gene discussed is NF1; the disease is gastrointestinal stromal tumor.